Uppsala-based Emplicure kicks off the autumn term by advancing their main project Empli03. On Tuesday last week, British authorities approved the company's application to conduct a clinical pharmacokinetic study with the candidate. BioStock asked Emplicure's CEO Torbjörn W. Larsson what the announcement means for the company and what the next step in the project is.

Read the article at biostock.se:

https://www.biostock.se/en/2022/09/emplicures-pk-study-with-empli03-approved/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

https://news.cision.com/emplicure-ab/r/biostock-emplicure-s-pk-study-with-empli03-approved,c3629375

(c) 2022 Cision. All rights reserved., source Press Releases - English